Literature DB >> 2833462

Neurotoxicity of antituberculous drugs in a patient without active tuberculosis.

D Leppert1, W Waespe.   

Abstract

A 56-year old patient presented 3 months after initiation of an antituberculous regimen with Isoniacid (INH, 5 mg/kg daily), Ethambutol (20 mg/kg daily) and Rifampicin (675 mg daily) a mild sensory polyneuropathy and a bilateral retrobulbar neuritis which progressed to a severe optic atrophy. Multiple hyperintense foci were detected with NMR-imaging in the cerebral white matter suggestive of demyelination. INH and Ethambutol are known for their neurotoxic effects but suggestion was made that neurologic signs may not be due to drug neurotoxicity but could be induced by immunological processes initiated by the tubercle bacillus. In the reported patient the suspected tuberculosis of the urogenital tract was never proved histologically. Most likely his neurological symptoms were therefore cause by the administration of INH and Ethambutol. Patients with a low serum zinc level and a slow acetylation of INH are reported to be at special risk; both factors were present in our patient.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2833462     DOI: 10.1007/BF02334404

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  2 in total

1.  Risk factors for ethambutol optic toxicity.

Authors:  Katherine Anne Talbert Estlin; Alfredo A Sadun
Journal:  Int Ophthalmol       Date:  2009-02-11       Impact factor: 2.031

2.  Letter to the Editor: Pre-Existing Neuropathy Favours SARS-CoV-2 Vaccination Associated Guillain-Barre Syndrome.

Authors:  Josef Finsterer
Journal:  J Korean Med Sci       Date:  2022-07-04       Impact factor: 5.354

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.